Lilly Halts Hanmi BTK Inhibitor Trial For RA, Mulls Other Indications

Render illustration of Clinical Trial title on medical documents
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from R&D

More from Scrip